1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6F842B654E065A2B700258BB00041CCC2
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/building-more-effective-medical-affairs-product-launch-teams-respiratory-segment?opendocument
18
19opendocument
2044.220.255.141
21
22
23best-in-class.com
24/bestp/domrep.nsf
25BMR




» Products & Services » » Medical Affairs » Launch Optimization

Building More Effective Medical Affairs Product Launch Teams: Respiratory Segment

ID: POP-392


Features:

12 Info Graphics

32 Data Graphics

650+ Metrics

18 Narratives


Pages: 56


Published: 2024


Delivery Format: Shipped


 

License Options:


Buy Now

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • STUDY SNAPSHOT
  • KEY FINDINGS
  • VIEW TOC AND LIST OF EXHIBITS
Medical Affairs teams play a crucial role in supporting respiratory product launches, ensuring that new treatments are effectively positioned and communicated to healthcare specialists, providers and patients.

Best Practices, LLC conducted this research to investigate the evolving role of Medical Affairs in respiratory product launches. The report examines shifting roles and responsibilities, cross-functional alignment, performance metrics, resourcing, activity effectiveness, launch timelines, and the deployment of digital tools within the respiratory therapeutic area. The report also identifies critical success factors and challenges that are vital for achieving launch excellence in the respiratory therapeutic segment.

Industries Profiled:
Pharmaceutical; Biotech; Diagnostic; Chemical; Health Care; Biopharmaceutical; Consulting; Consumer Products


Companies Profiled:
AstraZeneca; BELLUS Health; BIAL; bioMerieux; Boehringer Ingelheim; Cipla; Eurofarma; Genentech; Grünenthal; Labaid Group; Matinas BioPharma; MEDiSTRAVA; Novartis; Sandoz; Sunovion; Vertex Pharmaceuticals

Study Snapshot

Best Practices, LLC engaged 20 Medical leaders from 16 leading life sciences companies in this benchmarking research study. Medical Directors and upper management executives represent nearly four-fifths of the leaders who shared data and insights on Medical launch activities in this study.

Key topics covered in this report include:

  • Medical Leadership Roles and Launch Activity Effectiveness in Respiratory Segment
  • Ensuring Cross-functional Alignment and Collaboration in Respiratory Product Launches
  • Medical Launch Evolution in Respiratory Segment
  • Respiratory Product Launch Activities Timeline, Performance Tracking, and Resourcing
  • Critical Success Factors and Major Pitfalls for Medical Affairs During Respiratory Product Launches
  • Digital Launch Implementation and Impact in Respiratory Segment
  • Launch Tool Deployment for Respiratory Products

Key Findings

Select key insights uncovered from this report are noted below. Detailed findings are available in the full report.

  • Medical Leadership Roles: The top quartile of 26 high-value activities includes planning advisory boards, training internally on disease state, developing medical strategy, conducting medical education and ensuring medical communication execution.
Table of Contents

Sr. No.
Topic
Slide No.
I.
Executive SummaryPg. 4
II.
Section I: Launch Excellence and Medical’s Role & Activity EffectivenessPg. 6-12
III.
Section II: Ensuring Cross-functional Alignment and CollaborationPg. 13-15
IV.
Section III: Adopting to Ongoing Changes in Medical LandscapePg. 16-20
V.
Section IV: Launch Timeline, Preparedness Metrics, and ResourcingPg. 21-26
VI.
Section V: Critical Success Factors and Major PitfallsPg. 27-32
VII.
Section VI: Digital Influence on Launch Processes and Launch Tool DeploymentPg. 33-41
VIII.
Section VII: Participant DemographicsPg. 42-43
IX.
Section VIII: Detailed Benchmark Study DataPg. 44-55
X.
Section IX: About Best Practices, LLCPg. 56

    List of Charts & Exhibits

    I. Launch Excellence and Medical’s Role & Activity Effectiveness

    • Medical launch excellence framework
    • Medical Affairs’ role in respiratory product launches
    • Medical leadership roles in respiratory product launches
    • Medical Affairs’ effectiveness in respiratory product launch activities
    • Most effective launch activities for Medical Affairs in respiratory segment
    • Improvement opportunities for Medical Affairs around respiratory product launch activities

    II. Ensuring Cross-functional Alignment and Collaboration

    • Medical Affairs’ work with internal colleagues to ensure successful respiratory product launches
    • Role of Medical Affairs group in cross-functional respiratory product launch teams

    III. Adopting to Ongoing Changes in Medical Landscape

    • Change fronts for Medical launch evolution
    • Medical Affairs’ launch evolution around digital data dissemination and communication
    • Medical Affairs’ launch evolution around medical education
    • Medical Affairs’ launch evolution around organizational support

    IV. Launch Timeline, Preparedness Metrics and Resourcing

    • Medical Affairs’ respiratory product launch activities timeline
    • Total annual Medical Affairs launch investment in U.S. dollars and number of FTEs for respiratory products during each of the years in launch phase
    • Launch dashboard and information used with the dashboard for respiratory segment
    • Percentage of total Medical Affairs launch investment allocated to each of the listed Medical Affairs activities
    • Percentage of total Medical Affairs launch FTEs allocated to each of the listed Medical Affairs activities

    V. Critical Success Factors and Major Pitfalls

    • Critical success factors for Medical Affairs in respiratory product launches
    • Areas where advanced team planning is key for respiratory product launches
    • Six critical areas for successful Medical Affairs launch readiness in respiratory segment
    • Major pitfalls for Medical Affairs during respiratory product launches
    • Six major challenge areas for Medical Affairs during respiratory product launches

    VI. Digital Influence on Launch Processes and Launch Tool Deployment

    • Post-pandemic digital technology utilization in Medical Affairs during respiratory product launches
    • Impact of digital technologies on current and future respiratory product launch processes
    • Digital launch tool deployment and impact
    • Impact of top three digital activities that Medical leads in respiratory segment
    • Impact of digital activities and programs used to support a successful respiratory product launch
    • Top digital tools that can bring success to Medical Affairs product launch activities
    • Fast-growing digital tools that are impacting Medicals’ launch strategy
    • Example of a valuable digital tool that supports launch activities

    VII. Participant Demographics

    • Geographic responsibility of benchmark partners

    VIII. Detailed Benchmark Study Data

    • Role served by Medical Affairs in respiratory product launches
    • Medical Affairs’ launch role effectiveness in respiratory segment
    • Role served by Medical Affairs in planning, research, and education activities in respiratory segment
    • Role served by Medical Affairs in data dissemination and organizational support activities in respiratory segment
    • Role served by Medical Affairs in research activities in respiratory segment
    • Role served by Medical Affairs in education and data dissemination support activities in respiratory segment
    • Role served by Medical Affairs in organizational support activities in respiratory segment
    • Medical Affairs launch activity involvement timeline - Evidence generation and field-based medical activities in respiratory segment
    • Medical Affairs launch activity involvement timeline - Medical information and medical regulatory activities in respiratory segment
    • Medical Affairs launch activity involvement timeline - HEOR activities and medical / scientific communications in respiratory segment
    • Medical Affairs launch activity involvement timeline - Independent medical education and external engagement activities in respiratory segment